C4PAIN ApS: Financial statements 2014
CVR: 32292402
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 285,360 and a net result of DKK 240,807 compared with DKK 1,596,308 the year before. Equity in the 2014 report amounted to DKK 760,612. The solvency ratio was 56.4%.
- Gross Profit
- DKK 285,360
- Profit/Loss
- DKK 240,807
- Equity
- DKK 760,612
- Total Assets
- DKK 1,349,705
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 285 t. | 241 t. | 761 t. | - |
| 2013 | - | -448 t. | 1.6 mio. | 520 t. | - |
| 2012 | - | 2.1 mio. | -386 t. | 2.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 23, 2014, Lars Arendt-Nielsen has left the board of directors of C4PAIN ApS.
As of October 23, 2014, Claus Henrik Christiansen has left the board of directors of C4PAIN ApS.
As of October 23, 2014, Henrik Bernt Sanders has left the board of directors of C4PAIN ApS.
C4PAIN ApS has published its annual report for 2013. Gross profit came to DKK -448,496, and the net result was DKK 1,596,308.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.